Valeo Financial Advisors, LLC Cardiff Oncology, Inc. Transaction History

Valeo Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$6.65 - $10.04 $14,962 - $22,589	-2,250 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$9.1 - $19.57 $20,475 - $44,032	2,250 New	2,250 $21,000
Q3 2020 Oct 28, 2020	SELL	$4.25 - $14.19 $0 - $0	0 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$0.78 - $5.1 $0 - $0	0 New	0 $0

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $195M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.